ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO617

Notch Signaling Regulates Renal Urothelial Cell Proliferation During Experimental Urinary Tract Obstruction

Session Information

  • Pediatric Nephrology - II
    November 05, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1800 Pediatric Nephrology

Authors

  • Grounds, Kelly, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
  • Miehls, Alexa, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
  • Li, Birong, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
  • Becknell, Brian, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
  • Jackson, Ashley R., Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
Background

Urinary Tract Obstruction (UTO) is a leading cause of pediatric chronic kidney disease (CKD). While no interventions can prevent CKD progression, heterogenous outcomes suggest differences in ability of the kidney to adapt to hydrostatic pressure and pelvicalyceal dilatation. Congenital and acquired UTO triggers protective urothelial remodeling. Basal Keratin 5 (K5)-UCs function as age-restricted progenitors, giving rise to protective apical Uroplakin (UPK)-UCs, but the molecular regulation of renal K5-UC progenitors is unknown. The Notch signaling pathway regulates progenitor proliferation and differentiation in other organ systems. Thus, we hypothesize that the Notch signaling pathway governs renal K5-UCs during UTO.

Methods

We profiled the expression of members of the Notch signaling pathway using RNAscope (Jag2, Notch1, Dll1), immunohistochemical (ICH) and immunofluorescent (IF) localization (Notch1, NICD, RBPJ, Hes7). We used Megabladder mice (Mgb, congenital lower UTO), and unilateral ureteral obstruction (UUO, acquired upper UTO) to model UTO. We used K5CreERT2/+;RBPJfl/fl;R26tdT/+ mice (RBPJ-cKO) to inducibly disrupt Notch signaling in K5-UCs and compared to RBPJfl/fl;R26tdT/+ (control). We investigated the impact of Notch loss of function on urothelial integrity using IF (K5, UPK, Ki67).

Results

Renal urothelium expresses Jag2, Dll1 (ligands), and Notch1 (receptor), but low or undetectable levels of NICD (activated Notch) during homeostasis. UTO (both Mgb & UUO) leads to increased NICD in K5-UCs, thus, we proceeded to disrupt Notch during UTO. After validating deletion of RBPJ (loss of Notch function) in K5-UCs, we then performed UUO in RBPJ-cKO and control mice. At post-operative day 2 (peak stage of UTO-induced urothelial proliferation) RBPJ-cKOs exhibited increased Ki67 in K5-UCs compared to controls.

Conclusion

Our study suggests renal K5-UC progenitors are regulated by the Notch signaling pathway during UTO. Further studies are warranted to determine whether increased K5-UC proliferation in RBPJ-cKOs leads to impaired renal urothelial remodeling, and whether this impacts renal function. Nevertheless, these findings advance our understanding of renal adaptation to UTO, and implicate a potential signaling pathway with therapeutic utility for mitigating obstructive nephropathy.

Funding

  • NIDDK Support